{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-018871","form_type":"8-K","ticker":"BAX","cik":"0000010456","company_name":"BAXTER INTERNATIONAL INC","filed_at":"2025-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.788876+00:00","generated_at":"2026-05-27T03:52:18.759397+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Baxter CEO Almeida retires; Brent Shafer appointed interim CEO; Heather Knight named COO","bullets":["José Almeida retired as CEO/Chair effective Feb 3, 2025; will serve as Special Advisor through Oct 31, 2025.","Brent Shafer (former Cerner CEO, Baxter director since 2022) appointed interim CEO and Chair; Board seeks permanent CEO.","Heather Knight named EVP and COO; previously led Medical Products & Therapies segment; reports to interim CEO.","Q4/FY2024 results expected in line with prior continuing ops guidance; earnings call scheduled for Feb 20, 2025.","2025 objectives: 4–5% operational sales growth and ~16.5% adjusted operating margin; tariffs impact not yet included."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-018871","json":"https://secwatch.observer/filing/0001193125-25-018871.json","markdown":"https://secwatch.observer/filing/0001193125-25-018871.md","text":"https://secwatch.observer/filing/0001193125-25-018871.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10456/000119312525018871/0001193125-25-018871-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10456/000119312525018871/d907276d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:52:18.759397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"010372e7b6","claim":"Brent Shafer was appointed as Interim Chief Executive Officer and Chair at BAXTER INTERNATIONAL INC.","evidence_excerpt":"the Board appointed Brent Shafer as interim CEO of the Company and Chair of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10456/000119312525018871/0001193125-25-018871-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer and Chair"}]},{"claim_id":"59a4eb7bf0","claim":"Nancy Schlichting was appointed as Lead Independent Director at BAXTER INTERNATIONAL INC.","evidence_excerpt":"Nancy Schlichting was appointed Lead Independent Director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10456/000119312525018871/0001193125-25-018871-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Lead Independent Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}